...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cadernos de Saúde Pública >Indication, access, and use of medicines for chronic respiratory diseases in Brazil: results from the National Survey on Access, Utilization, and Promotion of Rational Use of Medicines in Brazil (PNAUM), 2014Indicación, acceso y utilización de medicamento
【24h】

Indication, access, and use of medicines for chronic respiratory diseases in Brazil: results from the National Survey on Access, Utilization, and Promotion of Rational Use of Medicines in Brazil (PNAUM), 2014Indicación, acceso y utilización de medicamento

机译：巴西用于慢性呼吸道疾病的药物的标示，获取和使用：2014年巴西全国药物获取，使用和促进合理使用情况全国调查（PNAUM）的结果印度，实用和实用药品

获取原文
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The study aimed to estimate the prevalence of self-reported chronic respiratory diseases and the indication, access to, and use of medicines, as well as their sources, in the Brazilian adult population. Data were analyzed on adults 20 years and older from the National Survey on Access, Utilization, and Promotion of Rational Use of Medicines in Brazil (PNAUM), conducted from September 2013 to February 2014. Prevalence of chronic respiratory diseases was 3% (95%CI: 2.7-3.3). Of these individuals, 58.1% (95%CI: 51.8-64.0) had an indication for pharmacological treatment. Of those with indication for treatment, 77.1% (95%CI: 71.0-82.8) were using at least one of the prescribed drugs. Total access to therapy was 91.4% (95%CI: 79.9-96.6), and more than half of individuals with chronic respiratory diseases purchased at least one of the drugs in retail pharmacies (57.3%). The most frequently reported drug class was the association of a corticosteroid plus a long-acting beta-2 agonist in inhalation form, the most common example of which was the association budesonide/formoterol (20.3%; 95%CI: 16.0-25.4). According to our study, prevalence of self-reported chronic respiratory diseases was lower than in previous studies published on the Brazilian population. Nearly half of the population reporting chronic respiratory diseases did not have an indication for pharmacological treatment. Among those with such indication, approximately one-fourth were not using medications during the study period, and for those who were on medication, although access was high, they had to pay for their medicines.
机译：这项研究旨在估计巴西成年人口中自我报告的慢性呼吸道疾病的患病率以及药物的适应症，获取和使用及其来源。根据2013年9月至2014年2月进行的巴西全国药物获取，使用和促进全国调查（PNAUM），分析了20岁及20岁以上成年人的数据。慢性呼吸道疾病的患病率为3％（95％） CI：2.7-3.3）。在这些个体中，有58.1％（95％CI：51.8-64.0）有药理治疗指征。在有治疗指征的患者中，77.1％（95％CI：71.0-82.8）使用至少一种处方药。接受治疗的总人数为91.4％（95％CI：79.9-96.6），并且超过一半的患有慢性呼吸系统疾病的人在零售药店购买了至少一种药物（57.3％）。报道最频繁的药物类别是皮质类固醇与吸入形式的长效β-2激动剂的联合，其中最常见的例子是布地奈德/福莫特罗的联合（20.3％; 95％CI：16.0-25.4）。根据我们的研究，自我报告的慢性呼吸系统疾病的患病率低于先前发表于巴西人口的研究。报告慢性呼吸道疾病的人口中有将近一半没有药物治疗指征。在有这种适应症的患者中，约有四分之一在研究期间未使用药物;对于那些正在接受药物治疗的患者，尽管获得药物的机会很高，但他们必须为药物付费。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号